The Latin America, Middle East and Africa Single-use Assemblies Market would witness market growth of 27.6% CAGR during the forecast period (2022-2028).
Deployment of single-use technology by CMOs can cut campaign as well as facility costs, hence reducing operating expenses and capital expenditures. Additionally, the utilization of single-use assemblies in CMOs decreases the complexity and lead time of upstream operations. In addition, they improve the quality of products by minimizing cross-contamination in subsequent procedures, particularly those involving potent or poisonous substances, such as antibody-drug conjugates or viral vectors.
In addition, severe regulatory requirements for manufacturing systems support the usage of single-use assemblies in CMOs. Conventional filtration assemblies were more susceptible to contamination. With the advent of single-use filtration assembly, the likelihood of contamination or disease transmission has been drastically diminished. This is accomplished through the sterilizing procedure.
The biopharmaceutical industry has made technological advances that have resulted in the development of single-use filter assemblies in the market. Manufacturers' shift in focus from small-molecule pharmaceuticals to large-molecule therapeutic products is driving market expansion in an upward direction. The growing availability of life science investments and funding is one of the primary factors driving the expansion of the market for single-use assembly.
The geriatric population in the region is increasing at a very fast pace. According to Statistics South Africa, the proportion of elderly South Africans (those aged 60 and over) has increased from 7.6% in 2002 to 9.1% in 2020. In recent years, South Africa has shifted from a country where communicable diseases, such as tuberculosis and HIV/AIDS accounted for the majority of deaths – which are often centered at younger ages to one where non-communicable diseases, like strokes and heart disease account for the majority of deaths.
The Brazil market dominated the LAMEA Single-use Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $153.1 million by 2028. The Argentina market is exhibiting a CAGR of 28.3% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 27.2% during (2022 - 2028).
Based on Solution, the market is segmented into Standard Solutions and Customized Solutions. Based on Product, the market is segmented into Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, and Others. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes. Based on Application, the market is segmented into Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Single-use Assemblies Market is Predict to reach $8.6 Billion by 2028, at a CAGR of 23.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech S.A. (Sartorius AG), Danaher Corporation, Merck Group, Avantor, Inc., Parker-Hannifin Corporation, Saint-Gobain Group (CertainTeed), Corning Incorporated, Repligen Corporation, and Entegris, Inc.
By Solution
By Product
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.